Literature DB >> 16204709

Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.

Mark A Stankewicz1, Craig S Mansour, Robert L Eisner, Keith B Churchwell, Byron R Williams, Steven R Sigman, James Streeter, Randolph E Patterson.   

Abstract

UNLABELLED: PET is a sensitive technique for the identification of viable myocardial tissue in patients with coronary disease. Metabolic assessment with (18)F-FDG is considered the gold standard for assessment of viability before surgical revascularization. Prior research has suggested that viability may be assessed with washout of (82)Rb between early and late resting images. Our objective was to determine whether assessment of myocardial viability with (82)Rb washout is reliable when compared with PET using (18)F-FDG.
METHODS: We performed PET for 194 patients referred for PET (18)F-FDG/(82)Rb to assess viability for clinical indications. We included 151 patients with resting defects >10% of the left ventricle (LV) (n = 159 defects). Patients with smaller resting (82)Rb defects (<10% LV) were excluded for the purpose of this study. PET images acquired with (82)Rb and (18)F-FDG defined viability by the mismatch between metabolism and perfusion ((18)F-FDG >125% of (82)Rb uptake in the (82)Rb defect). Evidence of viability with (82)Rb was assessed by the presence of (i) severity: (82)Rb counts in the defect >50% of (82)Rb in the normal zone of the resting PET images; (ii) washout: decrease of (82)Rb counts in the defect from early to late resting (82)Rb images <17% between the first 90-s image and the final 300-s image; or (iii) combined severity and washout criteria, which required positive criteria for (i) and (ii) to indicate viability.
RESULTS: Prevalence of viability by (18)F-FDG/(82)Rb criteria was 50% (n = 79). Severity criteria yielded a sensitivity of 76% and a specificity of 17%, washout criteria yielded a sensitivity of 81% and a specificity of 23%, and both criteria had a sensitivity of 63% and a specificity of 32%. Positive and negative predictive values were poor for all criteria. No correlation existed between (82)Rb washout and (18)F-FDG-(82)Rb mismatch (r(2) = 0.00). Multiple receiver-operating-characteristic plots showed very poor discrimination despite varying criteria for viability by (82)Rb (severity from 50% to 60% of normal zone, washout from 12% to 17%).
CONCLUSION: (82)Rb washout from early to late resting images, combined with quantitative severity of the resting (82)Rb defect, did not yield results equivalent to PET (18)F-FDG-(82)Rb mismatch and may not accurately assess myocardial viability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204709

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  The utility of 82Rb PET for myocardial viability assessment: Comparison with perfusion-metabolism 82Rb-18F-FDG PET.

Authors:  Jonathan B Moody; Keri M Hiller; Benjamin C Lee; Alexis Poitrasson-Rivière; James R Corbett; Richard L Weinberg; Venkatesh L Murthy; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2019-02-26       Impact factor: 5.952

2.  Washout of ⁸²Rb as a marker of impaired tissue integrity, obtained by list-mode cardiac PET/CT: relationship with perfusion/metabolism patterns of myocardial viability.

Authors:  David T Chien; Paco Bravo; Takahiro Higuchi; Jennifer Merrill; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-29       Impact factor: 9.236

3.  Viability assessment with MRI is superior to FDG-PET for viability: Con.

Authors:  Randolph E Patterson; Steven R Sigman; Robert E O'Donnell; Robert L Eisner
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

Review 4.  Cardiac PET perfusion: prognosis, risk stratification, and clinical management.

Authors:  Sharmila Dorbala; Marcelo F Di Carli
Journal:  Semin Nucl Med       Date:  2014-09       Impact factor: 4.446

5.  A novel gallium bisaminothiolate complex as a myocardial perfusion imaging agent.

Authors:  Karl Plössl; Rajesh Chandra; Wenchao Qu; Brian P Lieberman; Mei-Ping Kung; Rong Zhou; Bin Huang; Hank F Kung
Journal:  Nucl Med Biol       Date:  2007-11-19       Impact factor: 2.408

6.  Role of quantitative myocardial blood flow and 13N-ammonia washout for viability assessment in ischemic cardiomyopathy.

Authors:  Dominik C Benz; Paola Ferro; Nico Safa; Michael Messerli; Elia von Felten; Wenjie Huang; Dimitri Patriki; Andreas A Giannopoulos; Tobias A Fuchs; Christoph Gräni; Catherine Gebhard; Aju P Pazhenkottil; Philipp A Kaufmann; Ronny R Buechel
Journal:  J Nucl Cardiol       Date:  2019-03-20       Impact factor: 5.952

7.  The complexity of using resting myocardial perfusion to assess myocardial viability and predict functional recovery.

Authors:  Jennifer K Lang; John M Canty
Journal:  J Nucl Cardiol       Date:  2019-05-13       Impact factor: 5.952

Review 8.  Practical Implications of Myocardial Viability Studies.

Authors:  Wilter Dos Santos Ker; Thais Helena Peixoto Nunes; Marcelo Souto Nacif; Claudio Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2018-03       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.